# Elixirr International plc (ELIX.L) fundamentals

Data as of 2026-09-08. LSE, United Kingdom. Sector: Industrials / Professional Services. Price 603p, market value 299 millionp.

## Valuation
- **P/E (trailing): 16.3×** (5-yr avg 2404.8×, 3-yr avg 2100.8×). Elixirr International plc trades at 16.3× trailing earnings, well below its own five-year average of 2404.8×: cheap by its own standards. The Industrials median in the September 2026 study was 25.7×. Forward P/E is 8.5×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 0.54**. A PEG of 0.54 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 1.1×**. Each dollar of revenue is priced at 1.1×.
- **Price / book: 2.1×**. The shares trade at 2.1× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 5.0×**. Enterprise value is 5.0× operating earnings before depreciation, the multiple that ignores how the company is financed; below 8× is inexpensive for most sectors.
- **Free-cash-flow yield: 20.1%** (5-yr avg 0.1%). Free cash flow equals 20.1% of the market value, above its five-year average of 0.1%, so the shares are cheaper on cash than they have usually been. Above 5% is generally attractive.
- **Earnings yield: 6.1%**. The inverse of the P/E: 6.1% of the price is earned each year.

## Profitability
- **Gross margin: 31.0%**. Elixirr International plc keeps 31.0% of revenue after the direct cost of what it sells.
- **Operating margin: 21.8%**. 21.8% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 13.2%**. 13.2% of each dollar of sales reaches the bottom line.
- **Return on equity: 13.8%**. 13.8% on shareholders' equity is solid.
- **Return on invested capital: 23.8%**. Return on all capital, debt included, is 23.8%: comfortably above what that capital costs.
- **Return on assets: 14.4%**. Each dollar of assets produces 14.4% of profit.

## Growth
- **Revenue growth (1 yr): 34.4%** (3-yr 27.8%/yr, 5-yr 37.6%/yr). Revenue grew 34.4% over the last year, against 37.6% a year compounded over five years.
- **EPS growth (1 yr): 15.6%** (3-yr 14.0%/yr, 5-yr 27.5%/yr). Earnings per share rose 15.6%, slower than revenue, so margins compressed.
- **Free-cash-flow growth (3 yr): 26.9%/yr**. Free cash flow has compounded at 26.9% a year over three years, keeping pace with earnings: the growth is real cash.

## Financial health
- **Debt to equity: 0.24**. Debt is 0.24 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.4×**. It would take 0.4 years of operating earnings to repay net borrowings, within the comfortable range.
- **Interest coverage: 19.3×**. Operating profit covers interest 19.3× over, a safe margin.
- **Current ratio: 0.52** (quick 0.52). Current liabilities exceed current assets, so the company depends on ongoing cash generation or refinancing to pay the next year's bills.
- **Altman Z-score: 3.32**. A Z-score of 3.32 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 3.63%** (0p per share, trailing). Elixirr International plc yields 3.63%, an income-level yield.
- **Payout ratio: 43%** (25% of free cash flow). 43% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 5**. 5 straight years of increases.
- **Shareholder yield: 10.9%**. Dividends plus net buybacks return 10.9% of the market value a year.

## Price and momentum
- **Total return (1 yr): -13.9%** (YTD -23.9%, 3-mo -12.5%). The shares are down 13.9% over twelve months including dividends.
- **From 52-week high: -33.4%** (4.0% above the low). Trading 33% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 48**. An RSI of 48 is neutral.
- **Beta (1 yr): 0.36** (volatility 33%). Beta of 0.36 against the FTSE All-Share: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=ELIX.L · Page: https://foliofundamentals.com/stocks/elix.l

Not investment advice.